Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target
L Peyrin-Biroulet, W Sandborn, BE Sands… - Official journal of the …, 2015 - journals.lww.com
Official journal of the American College of Gastroenterology| ACG, 2015•journals.lww.com
OBJECTIVES: The Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE)
program was initiated by the International Organization for the Study of Inflammatory Bowel
Diseases (IOIBD). It examined potential treatment targets for inflammatory bowel disease
(IBD) to be used for a “treat-to-target” clinical management strategy using an evidence-
based expert consensus process. METHODS: A Steering Committee of 28 IBD specialists
developed recommendations based on a systematic literature review and expert opinion …
program was initiated by the International Organization for the Study of Inflammatory Bowel
Diseases (IOIBD). It examined potential treatment targets for inflammatory bowel disease
(IBD) to be used for a “treat-to-target” clinical management strategy using an evidence-
based expert consensus process. METHODS: A Steering Committee of 28 IBD specialists
developed recommendations based on a systematic literature review and expert opinion …
Abstract
OBJECTIVES:
The Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) program was initiated by the International Organization for the Study of Inflammatory Bowel Diseases (IOIBD). It examined potential treatment targets for inflammatory bowel disease (IBD) to be used for a “treat-to-target” clinical management strategy using an evidence-based expert consensus process.
METHODS:
A Steering Committee of 28 IBD specialists developed recommendations based on a systematic literature review and expert opinion. Consensus was gained if≥ 75% of participants scored the recommendation as 7–10 on a 10-point rating scale (where 10= agree completely).
RESULTS:
Lippincott Williams & Wilkins